--Fourth Annual OneMedForum Conference to Feature Emerging Healthcare and Life Science Companies--

TSX Venture Exchange: NVC

VANCOUVER, Jan. 5 /CNW/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies used to treat vascular disease, today announced that senior management will present at the OneMedForum 2011 Finance Conference on January 12, 2011 at 9:30 am PST.  The conference will be held at the Sir Francis Drake Hotel in San Francisco.

Neovasc CEO Alexei Marko will provide an overview of recent company developments and plans for 2011. 

Mr. Marko commented, "This is an exciting time for Neovasc, as patient enrollment is proceeding well in the COSIRA trial of our Neovasc Reducer™, a novel product in development for the treatment of refractory angina that we expect to launch in Europe next year.  Our biological tissue business continues to expand, and we are enthusiastic about the potential of our tissue technologies in the rapidly growing field of transcatheter heart valves.  I look forward to discussing our plans for these products and our other business activities with the many life sciences investors who will be in San Francisco next week to kick off the new business year."

An updated corporate presentation that includes the material Mr. Marko will discuss during the OneMedForum presentation will be posted on the Neovasc website at the time of the presentation on January 12, 2011, at

About Neovasc Inc.
Neovasc Inc. is a specialty vascular device company that develops, manufactures and markets medical devices for the rapidly growing vascular and surgical marketplace.  The company's current products include the Neovasc Reducer™, a novel product in development to treat refractory angina, as well as a line of advanced biological tissue technologies that are used to enhance surgical outcomes and as key components in a variety of third-party medical products such as percutaneous heart valves.  For more information, visit:

About OneMedForum
OneMedForum is a financial conference that includes industry-focused panel sessions, numerous networking opportunities and more than 125 presentations by some of the most promising emerging medical device, biotech and health information companies.  OneMedForum San Francisco 2011 runs concurrently with the J.P. Morgan Healthcare Conference, providing efficient access to the companies shaping the future of the rapidly changing healthcare landscape.  For more information, visit:

Statements contained herein that are not based on historical or current fact, including without limitation statements containing the words "anticipates," "believes," "may," "continues," "estimates," "expects," and "will" and words of similar import, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, among others, the following: general economic and business conditions, both nationally and in the regions in which the Company operates; history of losses and lack of and uncertainty of revenues, ability to obtain required financing, receipt of regulatory approval of product candidates, ability to properly integrate newly acquired businesses, technology changes; competition; changes in business strategy or development plans; the ability to attract and retain qualified personnel; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; liability and other claims asserted against the Company; and other factors referenced in the Company's filings with Canadian securities regulators. Although the Company believes that expectations conveyed by the forward-looking statements are reasonable based on the information available to it on the date such statements were made, no assurances can be given as to the future results, approvals or achievements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not assume the obligation to update any forward-looking statements except as otherwise required by applicable law.

SOURCE Neovasc Inc.

For further information:

Corporate contact:       U.S. media & investor contact:
Neovasc Inc.        GendeLLindheim BioCom Partners
Chris Clark       Barbara Lindheim 
604 248-4138       212 918-4650


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.